Pharmacological evaluation of [11C]A-84543: An enantioselective ligand for in vivo studies of neuronal nicotinic acetylcholine receptors

Life Sciences

Volumn 63, Issue 1, 1998, Pages

  Kassiou, Michael ^a,c   Scheffel, Ursula A ^b   Ravert, Hayden T ^b   Mathews, William B ^b   Musachio, John L ^b   London, Edythe D ^a   Dannals, Robert F ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

11 A 84543; Brain; Enantiomer; nAChR radiotracer

Indexed keywords

3 [(1 METHYL PYRROLIDINYL)METHOXY]PYRIDINE; BUTACLAMOL; CARBON 11; CYSTINE; EPIBATIDINE; HALOPERIDOL; KETANSERIN; LIGAND; LOBELINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; SCOPOLAMINE; TRACER; UNCLASSIFIED DRUG; CARBON; PYRROLIDINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG DISTRIBUTION; ENANTIOMER; MALE; MOUSE; NONHUMAN; RADIOACTIVITY; ANIMAL; METABOLISM; NERVE CELL; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; CARBON RADIOISOTOPES; LIGANDS; MALE; MICE; NEURONS; PYRROLIDINES; RECEPTORS, NICOTINIC; TISSUE DISTRIBUTION;

EID: 0031986931     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00240-9     Document Type: Article

References (17)

1. 1. M.D. ACETO and B.R. MARTIN. Med. Res. Rev. 2 43-62 (1982).
2. 2. P.B. SARGENT. A. Rev. Neurosci. 16 403-443 (1993).
3. 3. L.W. ROLE. Curr. Opin. Neurobiol. 2 254-262 (1992).
4. 4. A. NORDBERG, I. ALAFUZOFF and B. WINBALD. J. Neurosci. Res. 31 103-111 (1992).
5. 5. E.D. LONDON, M.J. BALL and S.B. WALLER. Neurochem. Res. 14 745-750 (1989).
6. 6. P.J. WHITEHOUSE, A.M. MARTINO, P.G. ANTUONO, P.R. LOWENSTEIN, J.T. COYLE, D.L. PRICE and K.J. KELLAR. Brain Res. 371 146-151 (1986).
7. 7. M. MAZIERE, D. COMAR, C. MARAZANO and G. BERGER. Eur. J. Nucl. Med. 1 255-258 (1976).
8. 8. A. NORDBERG, H. LUNDQVIST, P. HARTVIG, A. LILJA and B. LANGSTROM. Alzheimers Dis. Assoc. Discord. 9 21-27 (1995).
9. 9. H. NYBACK, C. HALLDIN, A. AHLIN, M. CURVALL and L. ERIKSSON. Psychopharmacology 115 31-36 (1994).
10. 10. B. BADIO and J.W. DALY. Mol. Pharmacol. 45 563-569 (1994).
11. 11. J.P. SULLIVAN, M.W. DECKER, J.D. BRIONI, D. DONNELLY-ROBERTS, D.J. ANDERSON, A.W. BANNON, C-H. KANG, P. ADAMS, M. PIATTONI-KAPLAN, M.J. BUCKELY, M. GOPALAKRISHNAN, M. WILLIAMS and S.P. ARNERIC. J. Pharmacol. Exp. Ther. 271 624-631 (1994).
12. 12. V. GERZANICH, X. PENG, F. WANG, G. WELLS, R. ANAND, S. FLETCHER and J. LINDSTROM. Mol. Pharmacol. 48 774-782 (1995).
13. 13. J.T. PATT, G. WESTERA, A. BUCK, S.R. FLETCHER and P.A. SCHUBIGER. J. Labelled Compds. Radiopharm. 37 355-356 (1995).
14. 14. A. HORTI, H.T. RAVERT, W.B. MATHEWS, J.L. MUSACHIO, A. KIMES, E.D. LONDON and R.F. DANNALS. J. Nuc. Med. 37 192P (1996).
15. 15. M.A. ABREO, N-H. LIN, D.S. GARVEY, D.E. GUNN, A-M. HETTINGER, J.T. WASICAK, P.A. PAVLIK, Y.C. MARTIN, D.L. DONNELLY-ROBERTS, D.J. ANDERSON, J.P. SULLIVAN, M. WILLIAMS, S.P. ARNERIC and M.W. HOLLADAY. J. Med. Chem. 39 817-825 (1996).
16. 16. M. KASSIOU, H.T. RAVERT, W.B. MATHEWS, J.L. MUSACHIO, E.D. LONDON and R.F. DANNALS. J. Labelled Comps. Radiopharm. 39 425-431 (1997).
17. 17. J.E. FLESHER, U. SCHEFFEL, E.D. LONDON and J.J. FROST. Life Sciences. 54 1883-1890 (1994).